How Americans view weight-loss drugs and their potential impact on obesity in the U.S., Pew Research Center (2024) Obesity and depression: Its prevalence and influence as a prognostic factor: a systematic review, Psychiatry Investigation (2020) Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies, Archives of General Psychiatry (2010) Wellbutrin label, GlaxoSmithKline Serotonin syndrome, Cleveland Clinic (2022) Controlled substances, Drug Enforcement Administration Label: Phentermine hydrochloride tablet, DailyMed (2014) Bupropion (Wellbutrin), National Alliance on Mental Illness Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
One clinical study examined patients switching to tirzepatide 5 mg from other GLP-1 receptor agonists
Surrounding tissues are not affected, but the fat cells are frozen to the point that they are destroyed
Based on current clinical evidence, tirzepatide (Zepbound) produces the highest average weight loss, followed by semaglutide (Wegovy), and then liraglutide (Saxenda)